New British lung cancer drug from AstraZeneca is hailed as a 'game changer'

The ground-breaking trial found patients who received osimertinib after surgery were 51 per cent more likely to be alive five years later than those given a dummy pill.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news